Stevanato Group SpA (FRA:87N) NonCurrent Deferred Revenue: €146 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:87N Stevanato Group SpA FRA:87N
87 GF Score
Price €17.40
GF Value €22.30
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Stevanato Group SpA NonCurrent Deferred Revenue?

Stevanato Group SpA FRA:87N +0.58% 87 NonCurrent Deferred Revenue is €146 Mil as of Jun. 2026. GuruFocus rates FRA:87N with a GF Score™ of 87/100 and a GF Value™ of €22.30 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Stevanato Group SpA's non-current deferred revenue for the quarter that ended in Jun. 2026 was €146 Mil.

Stevanato Group SpA NonCurrent Deferred Revenue Related Terms

Stevanato Group SpA NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Stevanato Group SpA's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stevanato Group SpA NonCurrent Deferred Revenue Chart

Stevanato Group SpA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Revenue
Get a 7-Day Free Trial 0.00 0.00 39.42 44.05 98.85

Stevanato Group SpA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.66 116.39 98.85 92.20 145.74
FRA:87N
87GF Score
Stevanato Group SpA FRA:87N
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of €146 Mil mean?
Stevanato Group SpA (FRA:87N) has a NonCurrent Deferred Revenue of €146 Mil as of Jun. 2026. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Stevanato Group SpA and its competitors.
Is Stevanato Group SpA's NonCurrent Deferred Revenue too high?
Stevanato Group SpA's current NonCurrent Deferred Revenue is €146 Mil. Overall, Stevanato Group SpA has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's NonCurrent Deferred Revenue compare to MMED and TFX?
Stevanato Group SpA's NonCurrent Deferred Revenue of €146 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Medical Devices & Instruments company?
A good NonCurrent Deferred Revenue depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Stevanato Group SpA and its competitors. Stevanato Group SpA's current NonCurrent Deferred Revenue is €146 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (FRA:87N) is currently considered Modestly Undervalued. The stock's GF Value™ is €22.30, compared to a current price of €17.40 — trading 22% below its estimated fair value. The current NonCurrent Deferred Revenue is €146 Mil. Stevanato Group SpA's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Stevanato Group SpA (FRA:87N), the current NonCurrent Deferred Revenue is €146 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stevanato Group SpA (FRA:87N) Overvalued in 2026?

Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued. The current stock price of €17.40 is trading 22% below its estimated GF Value™ of €22.30. GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.

Key valuation signals for FRA:87N:

  • NonCurrent Deferred Revenue: €146 Mil
  • GF Value™: €22.30 vs. price of €17.40 (22% below fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the FRA:87N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stevanato Group SpA Business Description

Other Exchanges STVN:USA87N:Germany
Address Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
87GF Score

Get the complete analysis for FRA:87N

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.40
Price
€22.30
GF Value